REVANCE THERAPEUTICS INC (RVNC) Stock Cash Flow
NASDAQ:RVNC - Nasdaq - US7613301099 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -184.44M | -323.99M | -356.42M | -281.31M | -282.09M | |||
| Depreciation Amortization | 3.77M | 11.38M | 33.73M | 19.85M | 10.25M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 0.00 | -2.72M | |||
| Change In Working Capital | -39.79M | -43.88M | 670.00K | -4.77M | 39.97M | |||
| Interest Paid | N/A | 15.09M | 12.23M | 5.03M | 2.53M | |||
| Taxes Paid | N/A | 300.00K | 700.00K | 0.00 | 100.00K | |||
| Other non cash items | 29.58M | 139.92M | 128.48M | 44.69M | 56.09M | |||
| OPERATING CASH FLOW | -190.89M | -216.57M | -193.55M | -221.54M | -178.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.02M | -6.89M | -3.21M | -10.38M | -4.22M | |||
| Other Investing Activity | -8.92M | 116.63M | -135.59M | -19.29M | 16.35M | |||
| INVESTING CASH FLOW | -12.94M | 109.74M | -138.80M | -29.67M | 12.13M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -16.58M | 30.16M | 87.05M | 0.00 | 278.31M | |||
| Stock Issued/Repurchased | 99.47M | 115.47M | 252.83M | 38.39M | 90.84M | |||
| Other Financing Activity | -1.19M | -9.06M | -8.19M | -8.53M | -37.67M | |||
| FINANCING CASH FLOW | 81.69M | 136.57M | 331.69M | 29.87M | 331.48M | |||
| CHANGE IN CASH | -122.13M | 29.73M | -660.00K | -221.34M | 165.11M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -190.89M | -216.57M | -193.55M | -221.54M | -178.50M | |||
| Capital Expenditure | -4.02M | -6.89M | -3.21M | -10.38M | -4.22M | |||
| FREE CASH FLOW | -194.91M | -223.46M | -196.76M | -231.92M | -182.72M | |||
All data in USD